Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

Tessera Therapeutics is planning to lay off 90 employees, the Flagship-founded biotech has warned. | Tessera Therapeutics is ...

Patients with a previously incurable blood cancer are benefiting from pioneering ethical gene immunotherapy.

Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing ...

As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...

CHANGE-seq-BE was developed to enable scientists to better understand base editors, an important class of CRISPR precise genome editors.

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

A sweeping genetic screen reveals how the brain is built and exposes a hidden gene behind a newly discovered childhood brain ...

Which genes are required for turning embryonic stem cells into brain cells, and what happens when this process goes wrong? In ...

Despite limited uptake, weight-loss drugs have topped drug sales in India by value — marking a shift in how people perceive ...

Kavita Mehta suffers from beta thalassaemia, a genetic condition preventing her body from producing sufficient haemoglobin ...